These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6133638)

  • 1. Proceedings of the Workshop on Implications of Recent Beta-blocker Trials for Post-Myocardial Infarction Patients. May 25-26, 1982, National Institutes of Health, Bethesda, Maryland.
    Circulation; 1983 Jun; 67(6 Pt 2):I1-111. PubMed ID: 6133638
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenergic blockade after myocardial infarction: clinical and public health implications of the reported beta-blocker clinical trials.
    Friedewald WT
    Circulation; 1983 Jun; 67(6 Pt 2):I110-1. PubMed ID: 6133641
    [No Abstract]   [Full Text] [Related]  

  • 3. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.
    Kramer JM; Hammill B; Anstrom KJ; Fetterolf D; Snyder R; Charde JP; Hoffman BS; Allen LaPointe N; Peterson E
    Am Heart J; 2006 Sep; 152(3):454.e1-8. PubMed ID: 16923412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of acute-phase beta-blocker trials in patients with myocardial infarction.
    May GS
    Circulation; 1983 Jun; 67(6 Pt 2):I21-5. PubMed ID: 6133643
    [No Abstract]   [Full Text] [Related]  

  • 5. A review of long-term beta-blocker trials in survivors of myocardial infarction.
    May GS
    Circulation; 1983 Jun; 67(6 Pt 2):I46-9. PubMed ID: 6133644
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of beta-blocker therapy on recurrent nonfatal myocardial infarction.
    Furberg CD; Bell RL
    Circulation; 1983 Jun; 67(6 Pt 2):I83-5. PubMed ID: 6133649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta blockade in acute myocardial infarction].
    Bosković D; Terzić B; Perunicić J; Zugić M; Beleslin BD
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():17-24. PubMed ID: 18196643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F; Beahan M; Klein L; Gheorghiade M
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction.
    Fonarow GC; Abraham WT; Cannon CP; Gheorghiade M; Sackner-Bernstein JD; Udelson JE;
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S54-9. PubMed ID: 14584479
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-blockers post-MI: an example of age discrimination?
    Gottlieb S
    Postgrad Med; 2002 Dec; 112(6 Suppl Heart):28-33. PubMed ID: 19667615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of beta-blockers in the treatment of patients after infarction.
    Pratt CM; Young JB; Roberts R
    Cardiol Clin; 1984 Feb; 2(1):13-20. PubMed ID: 6152718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost.
    Zuckerman IH; Weiss SR; McNally D; Layne B; Mullins CD; Wang J
    Am J Manag Care; 2004 Jul; 10(7 Pt 2):493-500. PubMed ID: 15298236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary prophylaxis with beta blockers after myocardial infarction].
    Bosković D
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():25-34. PubMed ID: 18193807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A beta-receptor blocker as an emergency precaution in acute myocardial infarction?].
    Strasser RH
    Dtsch Med Wochenschr; 1994 Dec; 119(49):1715. PubMed ID: 7988380
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction.
    Brand DA; Newcomer LN; Freiburger A; Tian H
    J Am Coll Cardiol; 1995 Nov; 26(6):1432-6. PubMed ID: 7594066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of beta blocker therapy in acute myocardial infarction.
    Norris RM
    Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):219-24. PubMed ID: 6146747
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
    Goldberger JJ; Bonow RO; Cuffe M; Dyer A; Greenland P; Rosenberg Y; O'Rourke R; Shah PK; Smith S
    Am Heart J; 2008 Mar; 155(3):455-64. PubMed ID: 18294477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.